BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35124694)

  • 21. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
    Kolstad A; Pedersen LB; Eskelund CW; Husby S; Grønbæk K; Jerkeman M; Laurell A; Räty R; Elonen E; Andersen NS; Brown PD; Kimby E; Bentzen H; Sundström C; Ehinger M; Karjalainen-Lindsberg ML; Delabie J; Ralfkiær E; Fagerli UM; Nilsson-Ehle H; Lauritzsen GF; Kuittinen O; Niemann C; Geisler CH;
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):428-435. PubMed ID: 28039078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
    Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
    J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation.
    Wu Q; Pesenacker AM; Stansfield A; King D; Barge D; Foster HE; Abinun M; Wedderburn LR
    Immunology; 2014 Jun; 142(2):227-36. PubMed ID: 24405357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
    Bhatt VR; Loberiza FR; Jing H; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Armitage JO; Akhtari M
    Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):409-415.e1. PubMed ID: 25816932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma.
    Gisselbrecht C
    Recent Results Cancer Res; 1998; 144():15-26. PubMed ID: 9304703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma.
    Gisselbrecht C
    Hematol Cell Ther; 1996 Aug; 38(4):297-304. PubMed ID: 8891721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Milgrom SA; Jauhari S; Plastaras JP; Nieto Y; Dabaja BS; Pinnix CC; Smith GL; Allen PK; Lukens JN; Maity A; Oki Y; Fanale MA; Nasta SD
    Cancer; 2017 Apr; 123(8):1363-1371. PubMed ID: 27984652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.
    Scordo M; Bhatt V; Hsu M; Omuro AM; Matasar MJ; DeAngelis LM; Dahi PB; Moskowitz CH; Giralt SA; Sauter CS
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):38-43. PubMed ID: 27713090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of 2-Deoxy-2-[
    Dai N; Zhou Y; Deng S; Sang S; Wu Y
    Contrast Media Mol Imaging; 2021; 2021():5510825. PubMed ID: 33958977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
    Metzner B; Müller TH; Gebauer W; Casper J; Kraemer D; Rosien B; Schumann-Binarsch S; Thole R; Köhne CH; Dreyling M; Hoster E; Pott C
    Ann Hematol; 2014 May; 93(5):803-10. PubMed ID: 24337447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study.
    Gao L; Xiang X; Zhang C; Gao L; Yang T; Wang S; Li B; Lou S; Yi Su ; Liu Y; Zhang X
    Hematology; 2019 Dec; 24(1):225-231. PubMed ID: 31081725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels.
    Eicher F; Mansouri Taleghani B; Schild C; Bacher U; Pabst T
    Hematol Oncol; 2020 Oct; 38(4):523-530. PubMed ID: 32594534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation.
    Luo C; Li Q; Li X; Wu G; Huang X; Zhang Y; Ma Y; Xie M; Sun Y; Huang Y; Huang Z; Xu S; Chen J
    Ann Transplant; 2021 Oct; 26():e933365. PubMed ID: 34635633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
    Yam C; Landsburg DJ; Nead KT; Lin X; Mato AR; Svoboda J; Loren AW; Frey NV; Stadtmauer EA; Porter DL; Schuster SJ; Nasta SD
    Am J Hematol; 2016 Jul; 91(7):672-6. PubMed ID: 27012928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation.
    Chitre S; Stölzel F; Cuthill K; Streetly M; Graham C; Dill C; Mohamedali A; Smith A; Schetelig J; Altmann H; Bornhäuser M; Mufti GJ
    Leukemia; 2018 Sep; 32(9):2020-2024. PubMed ID: 30026569
    [No Abstract]   [Full Text] [Related]  

  • 39. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
    Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous stem-cell transplantation in patients with HIV-related lymphoma.
    Balsalobre P; Díez-Martín JL; Re A; Michieli M; Ribera JM; Canals C; Rosselet A; Conde E; Varela R; Cwynarski K; Gabriel I; Genet P; Guillerm G; Allione B; Ferrant A; Biron P; Espigado I; Serrano D; Sureda A
    J Clin Oncol; 2009 May; 27(13):2192-8. PubMed ID: 19332732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.